Replies to post #87418 on Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

Blackhawks: I'm not sure why you're directing the BD partnership hyping at me? If you'll look back on my posts after returning from Vegas, I quoted Gerald about partnerships: "People will offer you x now, but down the road will pay 100x." What that means is that I was conveying to you NOT to expect a BP partnership right away and that Gerald said that is why he obtained the financing...so he could wait and get a better partnership down the road.

Blackhawks: It's obvious you have a Rainman-like obsession with logical fallacies, but I think you're equally good at annoying people too! After all, you and I are on the same team!

[facai88]

"it wasn't about duplicating an actual clinical patient trial but rather about confirming that the testing process was valid and reproducible"

Valid regarding what? That it does in fact detects AD in the brain and we didn't buy a lemon? Or was this validation more about the technique used in conducting the blood test? How can they assess proper technique without checking resulted accuracy? Without a specificity and sensitivity figure, can we really feel at ease that we didn't "buy a lemon"? I honestly do not understand.

Within the past few days I've read up on a few articles regarding AD diagnostics currently being studied...from sniffing peanut butter to another spinal fluid diagnostic, and they are all several years away to market, yet, at some level ours is months away from making a few sales but not any kind of article anywhere can be read about it recently. Peanut butter diagnostics makes better news than a boring old blood test?